Invicro has successfully supported 535+ clinical trials with a focus on scientific and operational excellence, project management expertise, and extracting crucial data with advanced analytics and artificial intelligence.
Wednesday, Feb. 8 | 11:40am
Edward Hogan chairs Biomarkers & Biospecimens
Thursday, Feb. 9 | 9:00am
Dr. Phillip Kuo presents Utilization of Artificial Intelligence and Lessons Learned from the Ph3 VISION Trial
Key obstacles and success of the VISION trial
Rationale underpinning the novel read criteria for the VISION trial
Use of artificial intelligence in the quantification of PET imaging
Combining quantification and personalized dosimetry to potentially improve outcomes